Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2
Simone Di Micco, Rahila Rahimova, Marina Sala, Maria Carmina Scala, Giovanni Vivenzio, Simona Musella, Graciela Andreï, Kim Remans, Léa Mammri, Robert Snoeck, Giuseppe Bifulco, Francesca Di Matteo, Vincenzo Vestuto, Pietro Campiglia, José Antonio Márquez, Alessio Fasano
Topics & Concepts
In silicoChemistrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)In vivoTripeptideRational designPharmacokineticsVero cellIn vitroDrug discoveryCoronavirus disease 2019 (COVID-19)Computational biologyPharmacologyBiochemistryNanotechnologyBiologyAmino acidMedicinePathologyGeneDiseaseInfectious disease (medical specialty)Materials scienceBiotechnologySARS-CoV-2 and COVID-19 ResearchInfluenza Virus Research StudiesComputational Drug Discovery Methods